1-14 of 14
Min Cheng
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 2113: HMPL-506, a novel, highly potent and differentiated menin-MLL inhibitor for the treatment of MLL-rearrangedand NPM1mutant acute leukemia in preclinical models

Min Cheng, Liang Ge, Zhihu Gao, Zeyu Zhong, An Jiang, Wei Zhang, Jia Hu, Shuwen Jiang, Na Li, Na Yang, Jian Wang, Yang Sai, Weiguo Qing, Yongxin Ren, Weiguo Su
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 2113.
https://doi.org/10.1158/1538-7445.AM2024-2113
Published: 22 March 2024
View article titled, Abstract 2113: HMPL-506, a novel, highly potent and differentiated menin-MLL inhibitor for the treatment of <em>MLL-rearranged</em>and <em>NPM1</em>mutant acute leukemia in preclinical models
Journal Articles

Abstract 1931: Targeting YAP1/TEAD signaling re-sensitizes MAPK/ERK pathway inhibitors in KRAS- driven cancer cells

Xianwen Yang, Guiping Li, Peiling Ren, Xiaoyun Shi, Ying Yu, Baoyu Hao, Pan Wang, Min Cheng, Guangxiu Dai
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 1931.
https://doi.org/10.1158/1538-7445.AM2024-1931
Published: 22 March 2024
View article titled, Abstract 1931: Targeting YAP1/TEAD signaling re-sensitizes MAPK/ERK pathway inhibitors in KRAS- driven cancer cells
Journal Articles

Abstract 543: Preclinical characteristic of HMPL-306, a CNS-penetrable dual inhibitor of mutant IDH1 and IDH2

Na Yang, Jia Hu, Tingwen Li, Juntao Yu, Dongxia Shi, Min Cheng, Zeyu Zhong, Jian Wang, Yang Sai, Weiguo Qing, Guangxiu Dai, Yongxin Ren, Michael Shi, Weiguo Su
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 543.
https://doi.org/10.1158/1538-7445.AM2023-543
Published: 04 April 2023
View article titled, Abstract 543: Preclinical characteristic of HMPL-306, a CNS-penetrable dual inhibitor of mutant IDH1 and IDH2
Journal Articles

Abstract 6321: HMPL-453, a highly selective inhibitor of fibroblast growth factor receptors 1, 2, and 3, displays potent activity in FGFR-altered tumor models

Jia Hu, Jun Ni, Longxian Jiao, Jinghong Zhou, Shiming Fan, Renxiang Tang, Wei Zhang, Xuelei Ge, Qihang Zhang, Juntao Yu, Ying Yu, Dongxia Shi, Min Cheng, Weifang Xue, Sumei Xia, Zeyu Zhong, Jian Wang, Yang Sai, Weiguo Qing, Guangxiu Dai, Yongxin Ren, Michael Shi, Weiguo Su
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 6321.
https://doi.org/10.1158/1538-7445.AM2023-6321
Published: 04 April 2023
View article titled, Abstract 6321: HMPL-453, a highly selective inhibitor of fibroblast growth factor receptors 1, 2, and 3, displays potent activity in FGFR-altered tumor models
Journal Articles

Abstract 2089: Evaluation of fruquintinib, a potent and selective oral VEGFR inhibitor, in combination with targeted therapies or immune checkpoint inhibitors in preclinical tumor models

Yongxin Ren, Qiaoling Sun, Jingwen Long, Shiming Fan, Renxiang Tang, Wei Zhang, Xuelei Ge, Jianxing Tang, Linfang Wang, Dongxia Shi, Hongbo Chen, Min Cheng, Weiguo Qing, Weiguo Su
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 2089.
https://doi.org/10.1158/1538-7445.AM2017-2089
Published: 01 July 2017
View article titled, Abstract 2089: Evaluation of fruquintinib, a potent and selective oral VEGFR inhibitor, in combination with targeted therapies or immune checkpoint inhibitors in preclinical tumor models
Journal Articles

Abstract 4187: Preclinical evaluation of sulfatinib, a novel angio-immuno kinase inhibitor targeting VEGFR, FGFR1 and CSF1R kinases

jinghong Zhou, Jun Ni, Min Cheng, Na Yang, Junqing Liang, Liang Ge, Wei Zhang, Jianxing Tang, qiaoling Sun, Fu Li, Jia Hu, Dongxia Shi, Hongbo Chen, Jingwen Long, Junen Sun, Fang Yin, Xuelei Ge, Hong Jia, Feng Zhou, Yongxin ren, Weiguo Qing, Weiguo Su
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 4187.
https://doi.org/10.1158/1538-7445.AM2017-4187
Published: 01 July 2017
View article titled, Abstract 4187: Preclinical evaluation of sulfatinib, a novel angio-immuno kinase inhibitor targeting VEGFR, FGFR1 and CSF1R kinases
Journal Articles

Targeting LUNX Inhibits Non–Small Cell Lung Cancer Growth and Metastasis

Xiaohu Zheng, Min Cheng, Binqing Fu, Xiaolei Fan, Qing Wang, Xiaoqing Yu, Rui Sun, Zhigang Tian, Haiming Wei
Journal: Cancer Research
Cancer Res (2015) 75 (6): 1080–1090.
https://doi.org/10.1158/0008-5472.CAN-14-1831
Published: 12 March 2015
View article titled, Targeting LUNX Inhibits Non–Small Cell Lung Cancer Growth and Metastasis
Open the PDF for Targeting LUNX Inhibits Non–Small Cell Lung Cancer Growth and Metastasis in another window
Includes: Supplementary data
Journal Articles

Abstract 4348: TGF-β enhances mir-455-5p expression that regulates tumorigenesis through UBE2B in betel quid-associated oral cancer

Chao-Min Cheng, Shine-Gwo Shiah, Ya-Wen Chen, Jang-Yang Chang
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 4348.
https://doi.org/10.1158/1538-7445.AM2014-4348
Published: 01 October 2014
View article titled, Abstract 4348: TGF-β enhances mir-455-5p expression that regulates tumorigenesis through UBE2B in betel quid-associated oral cancer
Journal Articles

Abstract 4675: Detection of ALK, ROS1, and RET translocations in non-small cell lung cancer (NSCLC) patients by intragenic differential expression analysis

Shih-Min Cheng, Cindy Barlan, Feras Hantash, Heather R. Sanders, Patricia H. Chan, Vladimira Sulcova, Marc A. Sanidad, Kevin Qu, Joann C. Kelly, Fatih Z. Boyar, Anthony D. Sferruzza, Frederic M. Waldman
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 4675.
https://doi.org/10.1158/1538-7445.AM2014-4675
Published: 01 October 2014
View article titled, Abstract 4675: Detection of <em>ALK</em>, <em>ROS1</em>, and <em>RET</em> translocations in non-small cell lung cancer (NSCLC) patients by intragenic differential expression analysis
Journal Articles

Microbiota Modulate Tumoral Immune Surveillance in Lung through a γδT17 Immune Cell-Dependent Mechanism

Min Cheng, Liting Qian, Guodong Shen, Geng Bian, Tingjuan Xu, Weiping Xu, Gan Shen, Shilian Hu
Journal: Cancer Research
Cancer Res (2014) 74 (15): 4030–4041.
https://doi.org/10.1158/0008-5472.CAN-13-2462
Published: 31 July 2014
View article titled, Microbiota Modulate Tumoral Immune Surveillance in Lung through a γδT17 Immune Cell-Dependent Mechanism
Open the PDF for Microbiota Modulate Tumoral Immune Surveillance in Lung through a γδT17 Immune Cell-Dependent Mechanism in another window
Includes: Supplementary data
Journal Articles

Abstract 183: Global knock-down of the cancer epigenome

Pei-Chi Peggy Hou, Ching-Chu Yen, Kuan-Der Lee, Hao-Chun Chang, Chao-Min Cheng, Yi-Shiuan Lin, H. Sunny Sun, Yu-Sun Chang, Tim H.-M. Huang, Shu-Huei Hsiao, Shaw-Jenq Tsai, Yu-Wei Leu
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 183.
https://doi.org/10.1158/1538-7445.AM10-183
Published: 15 April 2010
View article titled, Abstract 183: Global knock-down of the cancer epigenome
Journal Articles

Abstract 5074: Identification of Ras compartment-specific interacting proteins

Ze-Yi Zheng, Chiang-min Cheng, Xin-Rong Fu, Zhou Songyang, Eric C. Chang
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 5074.
https://doi.org/10.1158/1538-7445.AM10-5074
Published: 15 April 2010
View article titled, Abstract 5074: Identification of Ras compartment-specific interacting proteins
Journal Articles

Abstract #5046: Role of MKK1/2-ERK1/2 and PI3K-AKT signaling in erlotinib decrease Rad51 expression and cell survival in human non-small cell lung cancer cells

Yun-Wei Lin, Chao-Min Cheng, Jen-Chung Ko, Shih-Ci Ciou, Jhih-Yuan Jhan, Ying-Jhen Su, Szu-Ting Lin, Show-Mei Chuang
Journal: Cancer Research
Cancer Res (2009) 69 (9_Supplement): 5046.
Published: 01 May 2009
View article titled, Abstract #5046: Role of MKK1/2-ERK1/2 and PI3K-AKT signaling in erlotinib decrease Rad51 expression and cell survival in human non-small cell lung cancer cells
Journal Articles

SCC A2 and SCC A1 expression level in uterine cervical carcinogenesis.

Keng-Fu Hsu, Soon-Cen Huang, Cheng-Yang Chou, Meng-Ru Shen, Ya-Min Cheng, Yih-Fung Chen
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 85.
Published: 01 May 2005
View article titled, SCC A2 and SCC A1 expression level in uterine cervical carcinogenesis.